MedicineOphthalmologyPharmacotherapyOcular PharmacologyPhotodynamic TherapyRetinal PharmacotherapyRetinal Vascular DiseaseMacular NeovascularizationNeovascularizationOphthalmic Photodynamic Therapy
Verteporfin photodynamic therapy combined with intravitreal triamcinolone may improve the outcome of standard verteporfin photodynamic therapy in the treatment of choroidal neovascularization secondary to AMD. A significant improvement in VA was observed in a majority of treated patients and was maintained during the maximum follow-up. In addition, retreatment rates were lower than anticipated.